COMMUNIQUÉS West-GlobeNewswire

Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
28/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK ) today announced that it is joining the global initiative to raise awareness of Rare Disease Day®, an [...]
Strongbridge Biopharma plc to Host Conference Call on March 12, 2018 to Announce Fourth Quarter and Year-End 2017 Financial Results and Provide Corporate Update
28/02/2018
DUBLIN, Ireland and TREVOSE, Pa., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Terveystalo Plc: Notice of the Annual General Meeting
28/02/2018
Terveystalo Plc, Stock Exchange Release 28 February 2018 at 2:00 PM EET Notice is given to the shareholders of Terveystalo Plc of the Annual General Meeting to be held on Thursday, 12 April 2018 at 3:00 p.m. at Marina [...]
Midatech receives Orphan Drug Designation for MTD119 from the European Medicines Agency
28/02/2018
28 February 2018 Midatech Pharma PLC ("Midatech" or the "Company") Midatech receives Orphan Drug Designation for MTD119 from the European Medicines Agency Midatech (AIM: MTPH, Nasdaq: MTP), the international specialty [...]
Lexicon Pharmaceuticals Announces Poster Presentation at the 15th Annual ENETS Conference
28/02/2018
THE WOODLANDS, Texas, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), announced today that data from a poster highlighting XERMELO ® (telotristat ethyl) will be presented at the upcoming [...]
Trevena to Host Conference Call on March 7th to Discuss Full Year 2017 Financial Results
28/02/2018
CHESTERBROOK, Pa., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced that it will host a conference call on Wednesday, March 7, 2018 at 8:00 am EST to review financial results as of and for [...]
Melinta Therapeutics To Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018
28/02/2018
NEW HAVEN, Conn., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, [...]
Amicus Therapeutics Announces Full-Year 2017 Financial Results and 2018 Corporate Updates
28/02/2018
Galafold Expansion Continues with 360+ Fabry Patients Treated Today - on Track to Achieve FY18 Revenue Guidance of $75M-$85M Significant Progress Across Pompe Clinical, Regulatory and Manufacturing Activities - [...]
Cesca Therapeutics Inc. to Present at the 8th Spring Meeting of the International Society for BioProcess Technology (ISBiotech)
28/02/2018
RANCHO CORDOVA, Calif., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ: KOOL ) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today [...]
VitalHub Subsidiary HInext Adds 16 New Customers in New York State
28/02/2018
TORONTO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX-V: VHI ) is pleased to announce that its subsidiary HInext Inc. (“HInext”) has obtained 16 new customers in New York State, [...]
Axsome Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on March 7, 2018
28/02/2018
NEW YORK, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Evogene Reports Fourth Quarter and Full Year 2017 Financial Results
28/02/2018
REHOVOT, Israel, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ: EVGN ) (TASE: EVGN ), a leading biotechnology company developing novel products for life science markets through the use of a unique Computational [...]
Novelion Therapeutics Observes Rare Disease Day
28/02/2018
VANCOUVER, British Columbia, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN ), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]
Cara Therapeutics Doses First Patient in Phase 1 Trial of Oral KORSUVA™ (CR845/difelikefalin) in Chronic Liver Disease (CLD) Patients
28/02/2018
STAMFORD, Conn., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA ), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]
ProQR Announces Results for the Fourth Quarter and Full Year 2017 and Provides Business Update
28/02/2018
Key updates Runway into the second half of 2019: cash of €48.0 million at year-end expected to fund operations through anticipated clinical data readouts in three different programs. First patient dosed in the Phase 1/2 [...]
Akcea Therapeutics Recognizes Rare Disease Day by Spotlighting Several Historic “Firsts” for People Living with Familial Chylomicronemia Syndrome
28/02/2018
CAMBRIDGE, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious [...]
Emergent BioSolutions Awarded One-Year CDC Contract Valued at $26 Million for Vaccinia Immune Globulin Program
28/02/2018
GAITHERSBURG, Md., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) today announced a contract award by the Centers for Disease Control and Prevention (CDC) valued at $26 million over 12 months [...]
Syneos Health Reports Fourth Quarter and Full Year 2017 Results
28/02/2018
Highlights Combined Company net new business awards of $622.9 million for the fourth quarter and $2.55 billion for the full year 2017 representing growth of 16.5% for the full year 2017. Combined Company book-to-bill [...]
Achillion Raises Awareness for C3 Glomerulopathy With Launch of WeC3G™ Initiative as Part of Rare Disease Day 2018
28/02/2018
February 28, 2018 is the 11 th Annual Rare Disease Day Achillion sponsors initiative to help shine the light on C3G to raise awareness and understanding of this rare, chronic disease affecting the kidneys NEW HAVEN, [...]

Pages